Physician profile
Arpana Jain
NPI 1407081888
$41,156.51
in general payments reported to CMS, 2019-2025
22 companies · $21K in 2025
The $21K reported for 2025 was more than what 98% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $207 · 2021: $186 · 2022: $320 · 2023: $2,186 · 2024: $17K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Honoraria: $11K · Travel and Lodging: $6,195 · Food and Beverage: $2,690 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,356.00 |
| Honoraria | $11,000.00 |
| Travel and Lodging | $6,195.19 |
| Food and Beverage | $2,689.94 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,425.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $21,585.82 | 2019-2025 | Cohealyx, Recell, Permeaderm |
| Vericel Corporation | $16,297.75 | 2020-2025 | Epicel (Cultured Epidermal Autografts), Nexobrid |
| Molnlycke Health Care US, LLC | $1,160.47 | 2023-2025 | Mepilex Ag, Mlnlyckez-Flo Fluidized Positioner, Exufiber Ag+ |
| Imbed Biosciences INC. | $371.08 | 2023 | |
| Abbvie INC. | $247.08 | 2023-2025 | |
| Smith+Nephew, INC. | $192.54 | 2019-2025 | Biobrane, Oasis, Versajet |
| Acera Surgical, INC. | $188.67 | 2023-2025 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $187.90 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medline Industries Lp | $173.01 | 2019-2025 | Medline Industries, INC., Medline |
| Polynovo North America LLC | $146.03 | 2020-2024 | Novosorb Btm |
| Merck Sharp & Dohme LLC | $133.91 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $107.97 | 2023-2025 | |
| Polarityte, INC. | $81.47 | 2019-2020 | |
| Kerecis Limited | $73.01 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Mimedx Group, INC. | $48.61 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $45.17 | 2022-2023 | Quikclot |
| Access Pro Medical, LLC | $27.73 | 2025 | Matriderm |
| My01 INC. | $24.52 | 2022 | |
| Shionogi INC | $20.57 | 2022 | |
| Nevro Corp. | $19.06 | 2021 | |
| Ovik Health, LLC | $13.34 | 2019 | |
| Advanced Oxygen Therapy INC. | $10.80 | 2025 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arpana Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.